c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activation

By Liberatore Rachel A.   Goff Stephen P.  

International Immunology, Vol. 21, Iss. 4, 2009-04 ,pp. : 403-414

Oxford University Press

Access to resources Recommend Favorite

Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin’s lymphoma in a developing country?

By Ruiz-Delgado Guillermo J   Gómez-Almaguer David   Tarín-Arzaga Luz C   Cantú-Rodriguez Olga G   Urdaneta Carlos Alarcón   Rodríguez-Morales Uxmal   Calderón-Garcia Jackeline   Fernández-Vargas Omar   Montes-Montiel Maryel   Sánchez-Cárdenas Mónica   Ruiz-Argüelles Guillermo J  

Hematology, Vol. 17, Iss. 4, 2012-07 ,pp. : 193-197

Maney Publishing

Access to resources Recommend Favorite

CCR6 hi CD11c int B cells promote M-cell differentiation in Peyer's patch

By Ebisawa Masashi   Hase Koji   Takahashi Daisuke   Kitamura Hiroshi   Knoop Kathryn A.   Williams Ifor R.   Ohno Hiroshi  

International Immunology, Vol. 23, Iss. 4, 2011-04 ,pp. : 261-269

Oxford University Press

Access to resources Recommend Favorite

Lymphoma and the Control of B Cell Growth and Differentiation

By  

Current Molecular Medicine, Vol. 6, Iss. 3, 2006-05 ,pp. : 291-308

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice

By Rafferty Patricia   Egenolf Devon   Brosnan Kerry   Makropoulos Dorie   Jordan Jarrat   Meshaw Kay   Walker Mindi   Volk Amy   Bugelski Peter J.  

Journal of Immunotoxicology, Vol. 9, Iss. 1, 2012-03 ,pp. : 43-55

Informa Healthcare

Access to resources Recommend Favorite